Lithium inhibits amyloid secretion in COS7 cells transfected with amyloid precursor protein C100

Neuroscience Letters

Volumn 321, Issue 1-2, 2002, Pages 61-64

  Sun, X ^a   Sato, S ^a   Murayama, O ^a   Murayama, M ^a   Park, J M ^a   Yamaguchi, H ^b   Takashima, A ^a  

^a RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

^b GUNMA UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Amyloid; Glycogen synthase kinase 3 ; Lithium

Indexed keywords

AMYLOID; AMYLOID PRECURSOR PROTEIN; ENZYME INHIBITOR; GLYCOGEN SYNTHASE KINASE 3BETA INHIBITOR; LITHIUM CHLORIDE; TAU PROTEIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL STRAIN COS7; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; TECHNIQUE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BETA CATENIN; BRAIN; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; COS CELLS; CYTOSKELETAL PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENETIC VECTORS; GLYCOGEN SYNTHASE; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASES; LITHIUM CHLORIDE; NEURONS; PEPTIDE FRAGMENTS; TRANS-ACTIVATORS;

EID: 0037087220     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(01)02583-6     Document Type: Article

References (19)

1. In vitro phosphorylation of the cytoplasmic domain of the amyloid precursor protein by glycogen synthase kinase-3beta
2. Prospective clinicopathologic studies of schizophrenia: Accrual and assessment of patients
3. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
4. In vitro and in vivo inhibition of inositol monophosphatase by the bisphosphonate L-690,330
5. A topographical study of senile plaques and neurofibrillary tangles in the hippocampi of patients with Alzheimer's disease and cognitively impaired patients with schizophrenia
6. The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3
7. Activation of the Wnt signaling pathway: A molecular mechanism for lithium action
8. Inhibition of beta-amyloid formation by haloperidol: A possible mechanism for reduced frequency of Alzheimer's disease pathology in schizophrenia
9. Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3
10. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin
11. Substitution of a GSK-3beta phosphorylation site in presenilin 1 separates presenilin function from beta-catenin signaling
12. A molecular mechanism for the effect of lithium on development
13. Severe cognitive impairment in elderly schizophrenic patients: A clinicopathological study
14. Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease
15. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
16. Intracellular A-beta is increased by okadaic acid exposure in transfected neuronal and non-neuronal cell lines
17. Identification of 5.8kDa C-terminal fragments of Alzheimer amyloid β protein precursor generated in the lysosomal system
18. Presenilin 1 associates with glycogen synthase kinase-3beta and its substrate tau
19. The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3